NANOVIRICIDES, INC. Other Accrued Liabilities, Current
NANOVIRICIDES, INC. (NNVC) had Other Accrued Liabilities, Current of $31.00 thousand as of 2018-12-31, per its 10-Q filed 2019-02-14.
Discontinued › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2019-02-14
- 2018-12-31: Other Accrued Liabilities, Current $31.00K.
- 2018-06-30: Other Accrued Liabilities, Current $0.00.
- 2017-06-30: Other Accrued Liabilities, Current $4.86K.
| Period end | Other Accrued Liabilities, Current |
|---|---|
| 2018-12-31 | $31.00K 10-Q · filed 2019-02-14 |
| 2018-06-30 | $0.00 10-Q · filed 2019-02-14 |
| 2017-06-30 | $4.86K 10-K · filed 2018-10-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |